Lantern Pharma Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1,296.8% | – | – | – | -3,946.0% | -4,347.2% | – | – | – | – | – | – | |
| – | 17.0% | – | – | – | 50.9% | 4.5% | – | – | – | – | – | – | |
| – | 57.8% | – | – | – | 283.6% | 146.8% | – | – | – | – | – | – | |
| – | 336.8% | – | – | – | 1,304.8% | 68.6% | – | – | – | – | – | – | |
| – | 1.9% | – | – | – | 3.1% | 1.2% | – | – | – | – | – | – | |
| – | 98.1% | – | – | – | 3,424.9% | 3,218.3% | – | – | – | – | – | – | |
| – | -191.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -191.5% | – | – | – | 0.0% | 66,210.3% | – | – | – | – | – | – | |
| – | -1,392.1% | – | – | – | -587.9% | -1,126.1% | – | – | – | – | – | – | |
| – | -1,298.8% | – | – | – | -3,949.0% | -4,348.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.